Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
burger-menu close-panel
🤰 NEW: Pregnancy Centers Provided Over $452 Million in Services and Goods
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifeprex

mifeprex

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
9 results

Sort 9 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

January 22, 2026 Abortion Reporting: Oregon (2024) Abortion Reporting: Oregon (2024) January 20, 2026 Testimony of Monique Chireau Wubbenhorst, M.D. Before the Senate HELP Committee Testimony of Monique Chireau Wubbenhorst, M.D. Before the Senate HELP Committee January 14, 2026 New Report: How Overseas Abortion Drugs Are Flooding the U.S. New Report: How Overseas Abortion Drugs Are Flooding the U.S.
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

mifeprex

CLI Submits Comments to 3 Citizen Petitions Requesting FDA Action on Mifepristone

In July to August 2025, the Charlotte Lozier Institute submitted three comments responding to three citizen petitions submitted to the…

charlotte-lozier-institute Charlotte Lozier Institute
August 18, 2025
Please login to bookmark Close
mifeprex

The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone

This paper systematically examines, and refutes, claims to the effect that the abortion drug mifepristone is as safe as Tylenol…

Cameron Louttit, Ph.D.
May 27, 2025
Please login to bookmark Close
featured-image
mifeprex

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article…

Ingrid Skop, M.D., FACOG
May 23, 2024
Please login to bookmark Close
featured-image
mifeprex

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to…

charlotte-lozier-institute Charlotte Lozier Institute
May 13, 2024
Please login to bookmark Close
mifeprex

Lozier Institute Statement on Abortion Pill Lawsuit Filed by Alliance Defending Freedom

Charlotte Lozier Institute, which in 2021 revealed a dramatic surge in abortion pill-related emergency room visits, today applauded Alliance Defending…

charlotte-lozier-institute Charlotte Lozier Institute
November 18, 2022
Please login to bookmark Close
mifeprex

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell…

charlotte-lozier-institute Charlotte Lozier Institute
May 25, 2022
Please login to bookmark Close
mifeprex

Public Health Threat: Connecticut DPH Data Shows More Women Using Risky Abortion Method

Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates…

charlotte-lozier-institute Charlotte Lozier Institute
December 15, 2021
Please login to bookmark Close
mifeprex

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new…

charlotte-lozier-institute Charlotte Lozier Institute
November 16, 2021
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image